4-methyl-6-(trifluoromethyl)pyrimidin-2-amine,
5734-63-4,
CHEMBL504181,
4-methyl-6-(trifluoromethyl)-2-pyrimidinamine,
2-Amino-4-methyl-6-(trifluoromethyl)-pyrimidine,
2-Amino-4-trifluoromethyl-6-methyl pyrimidine,
2-amino-4-(trifluoromethyl)-6-methylpyrimidine,
4-methyl-6-(trifluoromethyl)pyrimidine-2-ylamine,
2qfo,
ZERO/005147,
AC1LCIEI,
HSP90 Inhibitor, 2,
AC1Q2H8G,
TimTec1_005036,
2-Pyrimidinamine, 4-methyl-6-(trifluoromethyl)-,
Pyrimidine, 2-amino-4-methyl-6-(trifluoromethyl)-,
SCHEMBL5361699,
CTK5A6697,
KS-00003REG,
ZINC39502,
DTXSID90344965,
CNTCLEOUAMWZGS-UHFFFAOYSA-N,
HMS1548E20,
ALBB-005393,
ANW-72248,
BDBM50270588,
CCG-42584,
MFCD00160470,
SBB013185,
STK503384,
AKOS000268217,
MCULE-5693631097,
RP23848,
RS-0054,
AJ-08855,
ST4105043,
TR-020019,
BB 0237698,
FT-0679108,
4-Methyl-6-trifluoromethylpyrimidin-2-ylamine,
W-6578,
4-Methyl-6-(trifluoromethyl)-2-pyrimidinylamine,
SR-01000396928,
4-Methyl-6-(trifluoromethyl)-2-pyrimidinylamine #,
J-507884,
S03-0212,
SR-01000396928-1,
SR-01000396928-2,
[4-methyl-6-(trifluoromethyl)-pyrimidin-2-yl]-amine,
4-Methyl-6-(trifluoromethyl)-2-pyrimidinamine, AldrichCPR,
A13,
CID600769,
4-methyl-6-(trifluoromethyl)pyrimidin-2-ol,
3-Methyl-1-(2-nitrophenyl)piperazine hydrochloride,